acid response element; RXR, retinoid X receptor; RXRE, retinoid X receptor response element; DR, direct repeat; CYP, cytochrome P450; EC 50 , effective concentration for half-maximal response; IC 50 , concentration of unlabeled compound required to prevent 50% of the radiolabeled ligand from binding to the receptor; GR, glucocorticoid receptor; TR, thyroid hormone receptor; ER, estrogen receptor; DBD, DNA-binding domain; LBD, ligand-binding domain.
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Vitamin A and its derivatives (retinoids) are natural compounds that play central roles in several physiological processes such as embryonic development, proliferation, differentiation, and apoptosis [reviewed in (1) ]. Beside their role in the physiology of normal cells, retinoids possess pharmacological properties used in dermatology and in cancer therapy, including epithelial cancers, precancerous lesions (2) and acute promyelocytic leukemia (3).
All-trans-retinoic acid (ATRA 1 ) (Figure 1 ), which is considered as one of the most active retinoid, is metabolized by several cytochrome P450s (CYPs) (4) . CYPs are haem proteins catalyzing the oxidation of several endobiotics and xenobiotics such as environmental pollutants and drugs. The CYP-mediated metabolism may transform some substrate into inactive compounds, but can also lead to the formation of biologically active metabolites. ATRA is metabolized into several oxidized metabolites including 4-oxo-RA, 4-OH-RA, 18-OH-RA and 5,6-epoxy-RA ( Figure 1 ) [reviewed in (5) ]. All of these metabolites have shown biological activity, e.g., 4-oxo-RA is a highly active modulator in embryogenesis (6) . It has also been shown that 4-oxo-, 4-OH-RA, and 5,6-epoxy-RA can inhibit the growth of several breast cancer cell lines (7, 8) . Some of these metabolites can inhibit the growth and induce rhabdomyosarcoma cells differentiation (9) , and regulate the expression of several genes involved in differentiation and embryogenesis (6, 10) . We have recently shown that ATRA metabolites, including 4-oxo-, 4-OH-, 18-OH-RA, and 5,6-epoxy-RA, can induce granulocytic differentiation of NB4 acute promyelocytic leukemia cells, elicit nuclear bodies reorganization, and induce the degradation of the chimeric protein PML-RARα (11) .
The retinoid signal is transduced by two families of nuclear receptors, the retinoic acid receptor (RAR) family comprising 3 isotypes, RARα, RARβ, RARγ, and the retinoid X receptor (RXR) family comprising also 3 isotypes, RXRα, RXRβ, RXRγ (12) . Each RAR and RXR isotype includes several isoforms. These receptors belong to the superfamily of nuclear hormone receptors and act as ligand-activated transcription factors [reviewed in (12, 13) ].
RARs function as heterodimer together with RXR. The ligand-receptor complexes act as by guest on November 17, 2017 http://www.jbc.org/
Downloaded from
4
inducible transcription regulators of several genes by binding to specific retinoic acid response elements (RARE). Two types of RARE were found on retinoic acid regulated genes, the DR-2 type, which is rarely encountered, and the DR-5 type, which is the most frequent.
The RXR can also act as homodimer on transcription activation via the retinoid X response element (RXRE) (DR-1), and also as heterodimer with several nuclear receptors, e.g., the thyroid hormone receptor (TR), the peroxisome-proliferator activated receptor (PPAR), and the vitamin D receptor (VDR), on their specific response elements. The natural ligands for the RARs are ATRA and its stereoisomers 9-cis-RA and 13-cis-RA, whereas RXRs are activated by 9-cis-RA.
Because ATRA isomers and metabolites are biologically active (6) (7) (8) (9) (10) (11) Stock solutions of retinoids were prepared in ethanol at 10 -2 M and stored protected from light at -80°C.
Cell culture. Cos-7 cells were maintained in Dulbecco's Modified Eagles Medium (DMEM, Gibco, BRL) supplemented with 10% fetal bovine serum (FBS, Gibco, BRL), 2 mM L-glutamine, 50 units/ml penicillin G, and 50 µg/ml streptomycin (Gibco, BRL). The cells were cultured at 37°C in a humidified atmosphere containing 5% CO 2 . Cell density was assessed with an electronic particle counter and size analyzer (Coulter Electronics, Hialeah, FL). Stock solutions of retinoids (at 10 -2 M in ethanol) were further diluted in culture medium to the final concentration indicated in each experiment. Final concentration of ethanol in culture medium did not exceed 1%. Stock solutions of retinoids were regularly checked for purity using reversed-phase HPLC analysis and did not show any contamination by ATRA.
All experimental procedures were light protected. 
RESULTS

Binding of retinoic acid metabolites and isomers to retinoic acid receptors.
To determine the binding of ATRA metabolites (4-oxo-, 4-OH-, 18-OH-, 5,6-epoxy-RA) and isomers (9-cis-, and 13-cis-RA) on the 3 RAR isotypes, we performed competition binding assays. Figure 3 shows that these nuclear receptors were over-expressed compared to controls. Dose-response effects of ATRA, its isomers (9-cis-and 13-cis-RA), and its 4 oxidized metabolites (4-oxo-, 4-OH-, 18-OH-RA and 5,6-epoxy-RA) on the transcription of the reporter gene were studied. 24 h after transfection, the cells were treated with increasing concentrations of the different retinoids (10 -11 to 5 × 10 -5 M) for another 24 h period, and the concentrations required to obtain half-maximal luciferase activity (EC 50 ) were determined by nonlinear sigmoidal analysis of the dose response experiments for each RAR isotype. Figure 4 shows representative dose-response curves obtained with ATRA and the metabolite 18-OH-RA for each RAR. A dose-dependent increase in luciferase activity was observed for the three RARs, and the EC 50 values with RARα and RARβ were very similar for ATRA and 18-OH-RA. Since all the retinoids tested could bind to and activate the three RARs, we next investigated their efficiency to stimulate the transcription of the reporter plasmid RARE-tkLuc in the presence of each RAR isotype by analyzing the fold-induction of luciferase activity. Cos-7 cells were cotransfected with RARE-tk-Luc plasmid and expression vectors for RARα, RARβ, or RARγ, separately. 24 h after transfection, the cells were treated with a single concentration of 100 nM of the different retinoids for 6 h. The choice of these treatment conditions were based on preliminary experiments that established that 100 nM was a non-saturating retinoid concentration at 6 h (data not shown).
The comparison of maximal luciferase activities showed that for each RAR isotype tested, ATRA, its isomers and metabolites were almost equipotent for the transactivation of the transcription of the RARE-tk-Luc reporter gene as shown in Figure 5 -A. However, the best induction of the transcription was obtained for RARα with all retinoids. As can be seen in Figure 5 -B, the fold-induction of luciferase activity with RARα was about 5-fold higher than with RARβ, and about 10-fold higher than with RARγ, whatever the retinoid tested. 
Time-dependent induction of luciferase activity via
DISCUSSION
Until recently, relatively little information was available on ATRA metabolism, and the oxidized metabolites of ATRA were considered as mere degradation products possessing low biological activity. In fact, ATRA oxidation to various compounds was thought of as a way to eliminate ATRA, and hence to negatively regulate its biological activities. However, several groups have shown that ATRA metabolites can induce the growth arrest and the differentiation of several cancer cell lines (7-9, 11). It has also been shown that some metabolite may be more active than ATRA, e.g., 4-oxo-RA is more effective in the modulation of positional specification in early embryo, and in the transcription induction of the development genes Hoxb-4 and Hoxb-9 (6). Beside their differentiating activity of acute promyelocytic leukemia cells, ATRA metabolites can also induce the degradation of the chimeric protein PML-RARα, and the reorganization of nuclear bodies (11) . We have also observed that ATRA metabolites differentiation activity seems to be mediated via the RARα pathway (11) . Considering the multiple biological activities of ATRA metabolites, we were interested to further understand their molecular mechanism of action, by assessing their binding capacity to the 3 retinoic acid receptors RARα, RARβ, RARγ, and also to evaluate their potency at transactivating a reporter gene via a specific retinoic acid response element (RARE).
Our data show that all ATRA metabolites and its isomers were able to bind the 3 RAR isotypes. They were also able to induce transcription of the reporter gene luciferase under the control of a RARE in the presence of any of the three RARs. to 600 nM with 13-cis-RA (17, 19) . A similar variability is observed with ATRA metabolites, between our study and the only available study in the literature concerning the 4-oxo-RA, the 4-OH-RA, and the 5,6-epoxy-RA, whatever the RAR considered (21) . This variability is probably due to the different experimental conditions used in all these studies, such as the use of retinoic acid related response elements, like the thyroid response element (TRE) (16) and the glucocorticoid response element (GRE) (15) , since at the time these studies were conducted, the RAREs were not yet described. In addition, some of these studies used chimeric receptor such as GR-or ER-(DBD)-RAR(LBD) on specific response element. This kind of experiment may explain the very low EC 50 of 0.6 nM found for ATRA with RARα, using GR(DBD)-RARα(LBD) on a GRE. Another factor that may explain the discrepancy between these studies is the different cell lines used. All the differences mentioned above make any comparison difficult and hazardous. In the present study, the results obtained with the use of a specific retinoic acid response element probably better reflect the reality of the ability and the efficiency of ATRA, its isomers and its metabolites to induce specific transcription of retinoid regulated genes. In addition, to our knowledge, this is the first report on the 18-OH-RA metabolite activity on the RARs, which happens to be a good activating ligand for RARβ and RARγ mediated transcription, as evidenced by the low EC 50 values of 14 nM for both.
The results obtained with 9-cis-RA need further comments, since it is a pan agonist for RARs and RXRs. We can not exclude that the responses observed with 9-cis-RA in terms of induction of the transcription of the luciferase gene via the DR5 element could have been due in part to the binding of 9-cis-RA to the RXR portion of the RAR/RXR heterodimer necessary for the activation of the transcription. However, if the RXR portion would have contributed to the response, it probably would have not been a predominant activation because, although a low EC 50 value (12 nM) was found with RARα, high EC 50 values were obtained for both RARβ and RARγ (173 and 58 nM, respectively), compared to the other retinoids tested.
Considering that the RXR protein content was the same in all the experiments, as it was the endogenous RXR of the Cos-7 cells, the only variable in these experiments was the overexpression of one of the transfected RAR. Hence, the fact that 9-cis-RA could also bind to RXR do not alter the observation that the EC 50 values determined were mostly dependent by guest on November 17, 2017
http://www.jbc.org/ Downloaded from on the specific RAR transfected, and mainly reflected the action of the ligand on these receptors. In addition, it has been shown that in a context of RAR/RXR heterodimer, the ligand-induced transcriptional activities of RXR are suppressed when complexed to RAR, because the binding of the ligand on RXR is subordinated to the binding of the RAR ligand (22, 23) .
Concerning the participation of the RXR portion to the response obtained with the ATRA metabolites, some evidences suggest that the RXR probably do not influence the response of luciferase activity induction since it has been reported, at least for 4-oxo-RA, a very weak binding to RXRα, whereas 4-oxo-RA bind to RARβ with a high affinity (6).
Moreover, experiments done in our laboratory on the activity of ATRA metabolites on the differentiation of the acute promyelocytic leukemia cells NB4-R2 resistant to ATRA differentiation induction (24) , because of the blocking of the RAR signaling pathway, showed that the metabolites were inefficient to induce the differentiation of these cells, even in combination with cAMP (unpublished data), whereas, it has been shown that specific RXR agonists and 9-cis-RA in combination with cAMP, can trigger the NB4-R2 cells toward granulocytic differentiation, probably by activating RXR/RXR homodimer (25). Taken together, these data strongly suggest that the metabolites of ATRA do not bind to the RXRs.
In view of our results and also of the data available in the literature, it clearly appears that ATRA metabolites and isomers act through RAR/RXR heterodimer, where the activation of the transcription of the RARE-tk-Luc reporter gene is initiated by the binding of these retinoids to the RAR portion of the heterodimer. Although the dose-response experiments have shown that the EC 50 s for ATRA, its isomers and its metabolites for the different RARs were different, we have also found that all these retinoids could transactivate the RARE-tk-Luc reporter plasmid with almost the same efficiency, whatever the RAR isotype considered. This apparent discrepancy between the EC 50 values and the efficiency of the retinoids tested could probably be explained as follows:
the EC 50 values appear to more reflect the affinity of the receptors for the different ligands, whereas the fold-induction of the luciferase gene transcription most probably reflects the interaction of the ligand-receptor complexes with the response element, and its efficiency to induce transcription, as was suggested before for synthetic retinoids (17) .
In this study, we also showed that there was major differences in the efficiencies of the retinoids tested to transactivate the transcription via RARE according to a given RAR isotype.
All the retinoids tested were about 5-fold more efficient with RARα than with RARβ, and about 10-fold more efficient than with RARγ, while the lowest EC 50 s with most of the retinoids tested were found for RARγ. Several hypotheses have been expressed among which the RARγ, and to a lesser extent the RARβ, are intrinsically less efficient at stimulating transcription than RARα, or the transfected cells lack cofactors required for maximal activation of RARβ and RARγ (17) .
In 
